Biotechnology, the practice of using live organisms for manufacturing products, plays an intricate role in our lives—from the food we eat to the medical treatment we receive. Though biotechnology is vital to supporting life, it may take a biotech company years or decades to study, test, and create these products. A significant amount of their work centers on research. Their ability to spend this amount of time required before releasing their products hinges on a financial incentive attached to their work. It would be naive to say their motives are based on greed. The market for biotechnology fuels their ability to create things that enhance and prolong our lives.
Producing the product can be significantly more inexpensive than years of research that went into creating it. Patents prevent others from manufacturing a product based on your research, data, and clinical trials. Obtaining a biotechnology patent protects their time and work while securing their ability to receive appropriate compensation. Although consumers may reject the costs associated with these drugs, patents prevent other companies from producing a similar and potentially dangerous drug that mimics yours.
Smaller biotech companies may not include production and sale as part of their business model. For them, intellectual property and the protection thereof is how they generate revenue. It isn’t uncommon for start-ups to operate at a loss or significantly underpay themselves during long R&D periods. Their success is based on selling their patented work to larger organizations capable of creating, for example, the vaccine or antibody on a larger scale. Start-ups or smaller biotech companies can attract more investors by having their IP patented.
On a deeper level, patents drive the evolution of the evolution and advancement of this industry. Though the patents last twenty years, they are also published a year and a half after being filed. Advancements within the biotechnology field have been cure-alls. There are side effects, which can be positive or negative, and other companies pivot their focus towards developing new solutions. Because the patents last twenty years, the company that created the product reaps the financial gain. The public has twenty years of buying a product from them. During this time, the product will also gain public acceptance. When competitors produce generic versions of the previously patented product, they have confidence that there is a market for it.
Inceptiv Law
The attorneys at Inceptiv Law work with and advise different types of life-science companies to include biotechnology, pharmaceutical, and medical devices. Contact us to schedule a consultation to learn more about how our firm assists entrepreneurs and high-growth companies.
Inceptiv
Latest posts by Inceptiv (see all)
- Nine Things You Can Do to Prepare to Sell Your Company - March 4, 2026
